NKP-1339 Clinical Trials
A NKP-1339 single agent dose escalation Phase I trial in United States is ongoing at the following two sites. The trial will accrue patients who have exhausted all standard treatment options for their tumor types.
Phase I Clinical Trial Sites in United States
NKP-2235 Clinical Trials
A NKP-2235 single agent dose escalation Phase I trial will be initiated shortly. The trial will accrue patients who have exhausted all standard treatment options for their tumor types.